Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 5Radiotherapy 4Carmustine 3Surgical Procedures, Operative 2Hyperbaric Oxygenation 2Ethanol 2Carboplatin 2pembrolizumab 1lonafarnib 1ipatasertib 1interleukin-4-Pseudomonas exotoxin 1dactolisib 1Verteporfin 1Tamoxifen 1Procarbazine 1Phosphorus-32 1Pemetrexed 1Neoadjuvant Therapy 1Lomustine 1Erlotinib Hydrochloride 1Dihematoporphyrin Ether 1Chlorotoxin 1Chemotherapy, Adjuvant 1Brachytherapy 1Arsenic Trioxide 17-tert-butyldimethylsilyl-10-hydroxycamptothecin 12-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gliosarcoma × lonafarnib × Clear all
NCT00083096 2015-02-10

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Unknown
30 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡